1. O, E., et al., Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. 2004. 86(5): p. 963-74.
2. Jacobs, J., et al., Metal degradation products: a cause for concern in metal-metal bearings? 2003(417): p. 139-47.
3. Sabbioni, E., et al., Cytotoxicity and morphological transforming potential of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblasts: an in vitro model. Nanotoxicology, 2014. 8(4): p. 455-464.
4. Papageorgiou, I., et al., The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials, 2007. 28(19): p. 2946-2958.
5. Wan, R., et al., Cobalt nanoparticles induce lung injury, DNA damage and mutations in mice. Part Fibre Toxicol, 2017. 14(1): p. 38.
6. C, M., et al., The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. 2007. 64(9): p. 609-15.
7. R, C., et al., Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. 2008. 23(5): p. 377-82.
8. S, R., et al., Comparative cytotoxicity and genotoxicity of cobalt (II, III) oxide, iron (III) oxide, silicon dioxide, and aluminum oxide nanoparticles on human lymphocytes in vitro. 2016. 35(2): p. 170-83.
9. Horev-Azaria, L., et al., Predictive toxicology of cobalt nanoparticles and ions: comparative in vitro study of different cellular models using methods of knowledge discovery from data. Toxicological sciences : an official journal of the Society of Toxicology, 2011. 122(2): p. 489-501.
10. M, O., et al., Mitochondria, oxidative stress and cell death. 2007. 12(5): p. 913-22.
11. Masui, T., et al., Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles. Biomaterials, 2005. 26(14): p. 1695-1702.
12. Goodman, S.B., et al., Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. The Journal of bone and joint surgery. British volume, 1998. 80(3): p. 531-539.
13. Dixon, S.J., et al., Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 2012. 149(5): p. 1060-72.
14. Dixon, S.J., et al., Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 2012. 149(5): p. 1060-1072.
15. Han, C., et al., Ferroptosis and Its Potential Role in Human Diseases. Front Pharmacol, 2020. 11: p. 239.
16. Xie, Y., et al., Ferroptosis: process and function. 2016. 23(3): p. 369-79.
17. Yang, W.S., et al., Regulation of ferroptotic cancer cell death by GPX4. Cell, 2014. 156(1-2): p. 317-331.
18. Jiang, L., et al., Ferroptosis as a p53-mediated activity during tumour suppression. 2015. 520(7545): p. 57-62.
19. Zou, Y. and S.L. Schreiber, Progress in Understanding Ferroptosis and Challenges in Its Targeting for Therapeutic Benefit. Cell Chem Biol, 2020. 27(4): p. 463-471.
20. Imai, H., et al., Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis. Current topics in microbiology and immunology, 2017. 403: p. 143-170.
21. Zhang, Y., et al., Ferroptosis inhibitor SRS 16-86 attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury. Brain research, 2019. 1706: p. 48-57.
22. Jiang, H., et al., Effects of cobalt nanoparticles on human T cells in vitro. Biol Trace Elem Res, 2012. 146(1): p. 23-9.
23. Dixon, S., et al., Ferroptosis: an iron-dependent form of nonapoptotic cell death. 2012. 149(5): p. 1060-72.
24. Yang, W., et al., Regulation of ferroptotic cancer cell death by GPX4. 2014. 156: p. 317-331.
25. Friedmann Angeli, J., et al., Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. 2014. 16(12): p. 1180-91.
26. Sabbioni, E., et al., Cytotoxicity and morphological transforming potential of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblasts: an in vitro model. 2014. 8(4): p. 455-64.
27. Yan, X., et al., alpha-Tocopherol protected against cobalt nanoparticles and cocl2 induced cytotoxicity and inflammation in Balb/3T3 cells. Immunopharmacol Immunotoxicol, 2018. 40(2): p. 179-185.
28. Liu, Y., et al., Alpha lipoic acid antagonizes cytotoxicity of cobalt nanoparticles by inhibiting ferroptosis-like cell death. J Nanobiotechnology, 2020. 18(1): p. 141.
29. Lu, L.-Q., et al., Targeting the pathways of regulated necrosis: a potential strategy for alleviation of cardio-cerebrovascular injury. Cellular and molecular life sciences : CMLS, 2021. 78(1): p. 63-78.
30. Thomas, V., et al., In vitro studies on the effect of particle size on macrophage responses to nanodiamond wear debris. 2012. 8(5): p. 1939-47.
31. Hallab, N.J.S., Biologic Responses to Orthopedic Implants: Innate and Adaptive Immune Responses to Implant Debris. 2016: p. S30-1.
32. Kaufman, A., et al., Human macrophage response to UHMWPE, TiAlV, CoCr, and alumina particles: analysis of multiple cytokines using protein arrays. 2008. 84(2): p. 464-74.
33. Imai, H., et al., Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis. 2017. 403: p. 143-170.
34. Chen, D., et al., ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. 2017. 36(40): p. 5593-5608.